Search for: "PREFERRED PHARMACEUTICALS, INC"
Results 141 - 160
of 431
Sort by Relevance
|
Sort by Date
31 Mar 2017, 9:00 am
Barron had little familiarity with pharmaceuticals and received little training from SafeTrust and IntegraRx. [read post]
25 Mar 2017, 11:10 am
Merrell Dow Pharma., Inc., 791 F. [read post]
17 Dec 2016, 7:00 am
Gelman Foundation Inc., which seeks to fund innovative research to cure breast cancer. [read post]
3 May 2016, 9:00 pm
Guest Post By: Paul Dietze and Mini Kapoor, Haynes and Boone, LLP[1] On March 18, 2016, the Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
7 Apr 2016, 6:25 am
Concordia Pharmaceuticals, Inc. v. [read post]
1 Apr 2016, 3:02 am
EMD Serono, Inc., 2016 WL 1086028 (N.D. [read post]
20 Mar 2016, 7:25 am
According to the FINRA action against Marshall, from January 6, 2011 through May 2, 2012, Marshall participated in the sale of $1.72 million of privately issued preferred stock of BioChemics, Inc. [read post]
19 Mar 2016, 10:13 am
Cephalon, Inc. v. [read post]
15 Mar 2016, 5:09 pm
Supreme Court’s March 24, 2015 opinion in Omnicare, Inc. v. [read post]
15 Mar 2016, 9:00 am
In doing so, the Second Circuit offered its first substantial interpretation of the Supreme Court’s March 2015 decision in Omnicare, Inc. v. [read post]
26 Feb 2016, 9:17 am
Hazeltine Research, Inc., 339 U.S. 827, 836 (1950) (“The general rule is that the licensee under a patent license agreement may not challenge the validity of the licensed patent in a suit for royalties due under the contract. [read post]
22 Feb 2016, 4:36 pm
After attending the PLUS D&O Symposium some years ago, several colleagues at Partner Re thought it might be worthwhile to provide D&O insurance professionals with historical overview of the evolution of Directors and Officers insurance (D&O) in the US marketplace. [read post]
17 Feb 2016, 10:19 am
General Atlantic — Founded in 1980, New York-based General Atlantic prefers to make more substantial investments from a dollars perspective in healthcare and a number of other sectors. [read post]
24 Dec 2015, 8:20 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., 777 S.E.2d 176 (S.C. 2015). [read post]
8 Dec 2015, 2:22 pm
Daiichi Sankyo Inc., a global pharmaceutical company with its U.S. headquarters in New Jersey, paid $39 million to resolve allegations of false claims against the United States and state Medicaid programs. [read post]
5 Nov 2015, 6:00 am
Mylan Pharmaceuticals Inc. v. [read post]
17 Oct 2015, 5:29 am
While the Paoli approach is unpopular with some judges who might prefer not to work so hard, the Advisory Committee heartily endorsed Paoli’s “any step” approach in its Note to the 2000 amendment. [read post]
24 Sep 2015, 11:31 am
Ivax Pharmaceuticals, Inc.,501 F.3d 1263 (Fed. [read post]
29 Jul 2015, 11:30 am
Physicians Healthsource, Inc. v. [read post]
17 Jul 2015, 9:48 am
IMS Health Inc., 564 U.S. ___, 131 S. [read post]
